Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 20 to 70 years~* Patients who were diagnosed with early-stage HCC, defined by modified UICC stage 1 or 2~* Patients with treatment-naive and recurrent HCC who have received treatment and achieved complete response at the time of screening~* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2~* Patients with insulin resistance (HOMA-IR \>=2.2)~Exclusion Criteria:~* Child Pugh class B or C~* Alcohol intake \>20g/day~* History of decompensation~* Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure \> 200/120 mmHg) or psychiatric illnesses which limit ability to exercise safely~* Who takes insulin sensitizer (sulfonylurea, biguanide, thiazolidinedione, glucagon-like peptide-1 agonist, dipeptidyl peptidase-4 inhibitor) or uses insulin~* Uncontrolled diabetes mellitus (Hemoglobin A1c \>10%)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Standard care (Type: NO_INTERVENTION): Hepatocellular carcinoma (HCC) patients with insulin resistance who underwent hepatic resection or radiofrequency ablation (RFA) will be enrolled. Patients included in the control arm will receive a booklet including information about physical activity recommendations and practice (education). After 12 weeks, they will also be provided mobile application and wearable device and perform exercise for 12 weeks.
- Mobile health (Type: ACTIVE_COMPARATOR): HCC patients with insulin resistance who underwent hepatic resection or RFA will be enrolled. Patients included in the intervention arm will receive both booklet and mobile health program. They will perform exercise daily with mobile application and wearable device (warm-up, stretching, aerobic, and strengthening) for 24 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).